ROSENDALE MARTIN P 4
4 · CYTOMEDIX INC · Filed Apr 18, 2011
Insider Transaction Report
Form 4
CYTOMEDIX INCCMXI.OB
ROSENDALE MARTIN P
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Other
Common Stock
2011-04-15+1,250→ 91,823 total
Footnotes (1)
- [F1]Received pursuant to a stock dividend on the Company's outstanding Series D Convertible Preferred Stock.